Inventor · disambiguated record
Mark S. Tichenor
Also filed as: TICHENOR MARK S
25 granted patents·10 pending applications·71 citations·filing 2004–2024
95Inventor score
Files withJANSSEN PHARMACEUTICA NV28BREITENBUCHER J GUY3JANSSEN BIOTECH INC2APODACA RICHARD1SANDIA CORP1
Top patents by PatentIndex Score
35 records- 0195US10487083B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 26, 2019·7 cites·12 claims
- 0295US10294226B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 21, 2019·11 cites·14 claims
- 0394US10364246B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 30, 2019·7 cites·9 claims
- 0493US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0593US11066406B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jul 20, 2021·3 cites·1 claims
- 0693US11059823B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·4 cites·37 claims
- 0791US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0891US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 0991US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 1090US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 1186US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1284US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 1381US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 1480US8598356B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2009·Granted Dec 3, 2013·4 cites·17 claims
- 1579US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 1679US8461159B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2009·Granted Jun 11, 2013·4 cites·24 claims
- 1775US12202831B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 21, 2025·0 cites·11 claims
- 1874US11787807B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 17, 2023·0 cites·55 claims
- 1973US8901111B2Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolaseBREITENBUCHER J GUY·Filed 2010·Granted Dec 2, 2014·3 cites·15 claims
- 2066US2020017498A1Small Molecule Inhibitors of the JAK Family of KinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2165US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 2264US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 2360US2023175038A1Crystal structure of btk protein and binding pockets thereofJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2459US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 2559US2023012167A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2658US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 2758US2023013755A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2855US2024158392A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2955US2014066412A1Heteroaryl substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3055US2014221322A1Heteroaryl substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3154US2024174662A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3250US10172856B22,4-diaminopyrimidine derivatives as histamine H4 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 8, 2019·0 cites·22 claims
- 3349US8877769B2Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 4, 2014·0 cites·24 claims
- 3448US7618524B1Polymeric salt bridges for conducting electric current in microfluidic devicesSANDIA CORP·Filed 2004·Granted Nov 17, 2009·2 cites·6 claims
- 3545US2009062294A1Heteroaryl-substituted urea modulators of fatty acid amide hydrolaseAPODACA RICHARD·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark S. Tichenor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →